Showing results (71-80 of 241) with videos related to
Sort By:
Pageof 25
Transfusion Science|May 7, 1998
Mammalian recombinant coagulation proteins: structure and functionG C White, E M Pickens, D K Liles, et al.American Journal of Hematology|July 1, 1993
Comparison of the behavior of normal factor IX and the factor IX Bm variant Hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sourcesJ B Lefkowitz, D M Monroe, C K Kasper, et al.Transfusion|September 1, 1979
Antithrombin III in fresh frozen plasma, cryoprecipitate, and cryoprecipitate-depleted plasmaP D Mintz, P M Blatt, W J Kuhns, et al.The Journal of Laboratory and Clinical Medicine|March 1, 1986
Granulocyte lysosomal cationic protein alters fibrin assembly: a possible mechanism for granulocyte control of clot structureM E Carr, D A Gabriel, J C Herion, et al.Biochemistry|February 18, 1992
The endothelial cell binding determinant of human factor IX resides in the gamma-carboxyglutamic acid domainJ R Toomey, K J Smith, H R Roberts, et al.Thrombosis and Haemostasis|February 12, 1999
TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) geneJ Y Chang, D M Monroe, J A Oliver, et al.Blood|July 1, 1983
Treatment of a high titer anti-factor-VIII antibody by continuous factor VIII administration: report of a caseG C White, R E Taylor, P M Blatt, et al.The Journal of Biological Chemistry|June 25, 1990
Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domainD M McCord, D M Monroe, K J Smith, et al.American Journal of Hematology|December 1, 1982
Factor VIII inhibitors: a clinical overviewG C White, C W McMillan, P M Blatt, et al.British Journal of Haematology|February 1, 1980
An agarose plate method for detecting alloantisera to coagulant factor IX and factor IX antigenH M Reisner, E A Strand, K S Chung, et al.Pageof 25